Raquel Rogers

Q: What is Raquel Rogers email address?

Email Raquel Rogers at leah.broyles@yahoo.com and raquel.rogers@takeda.com. This email is the most updated Raquel Rogers email found in 2026.

Q: How to contact Raquel Rogers?

To contact Raquel Rogers send an email to leah.broyles@yahoo.com or raquel.rogers@takeda.com. (updated on October 31, 2024)

Vice President Safety Therapeutic Area Head of Gastrointestinal, Inflammation and Neuroscience at Takeda | Cambridge, Massachusetts, United States

About Raquel Rogers

Raquel Rogers currently serves as the Vice President Safety Therapeutic Area Head of Gastrointestinal, Inflammation, and Neuroscience at Takeda, where she plays a pivotal role in ensuring the safety and efficacy of both investigational and marketed products. With over 20 Global Safety Physicians and Scientists under her leadership, Raquel oversees critical pharmacovigilance activities that span the entire product lifecycle, from pre-first-in-human (FIH) trials to regulatory submission. Her extensive background in clinical practice, epidemiology, and regulatory affairs enables her to provide strategic insights that enhance the benefit-risk assessments essential for informed decision-making in drug development.

At Takeda, Raquel is deeply involved in key projects that focus on risk management plans (RMPs) and signal detection, ensuring that safety data is meticulously analyzed and communicated across therapeutic areas. Her expertise in Good Clinical Practice (GCP) and clinical trials allows her to navigate complex regulatory landscapes effectively, fostering collaboration with cross-functional teams to optimize patient safety outcomes. Raquel’s critical thinking skills are instrumental in identifying potential safety signals and developing robust strategies to mitigate risks, which are crucial in the fast-paced pharmaceutical industry.

Moreover, Raquel is committed to advancing the field of pharmacovigilance through continuous research and the application of MedDRA coding, which enhances the precision of safety data reporting. Her ability to synthesize scientific information and engage with senior stakeholders positions her as a key influencer in shaping Takeda’s safety policies and practices. With a passion for innovation and a dedication to patient safety, Raquel Rogers exemplifies leadership in the evolving landscape of drug safety and therapeutic development.

Raquel Rogers Work